Mirae Asset Global Investments
REGN icon

Mirae Asset Global Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Mirae Asset Global Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.4M Buy
93,632
+9,024
+11% +$6.14M 0.09% 148
2026
Q1 		$65.4M Buy
84,608
+7,404
+10% +$5.67M 0.02% 96
2025
Q4 		$59.6M Buy
77,204
+14,635
+23% +$9.94M 0.17% 105
2025
Q3 		$35.2M Buy
62,569
+5,403
+9% +$3.05M 0.11% 151
2025
Q2 		$30M Buy
57,166
+4,080
+8% +$2.28M 0.1% 158
2025
Q1 		$33.3M Sell
53,086
-2,340
-4% -$1.61M 0.14% 126
2024
Q4 		$38.3M Buy
55,426
+9,845
+22% +$8.26M 0.16% 112
2024
Q3 		$46.9M Buy
45,581
+7,428
+19% +$8.27M 0.21% 90
2024
Q2 		$38.3M Sell
38,153
-83,172
-69% -$80.6M 0.19% 90
2024
Q1 		$104M Sell
121,325
-2,992
-2% -$2.85M 0.23% 84
2023
Q4 		$109M Sell
124,317
-936
-0.7% -$771K 0.22% 97
2023
Q3 		$103M Buy
125,253
+15,751
+14% +$12.4M 0.23% 90
2023
Q2 		$78.7M Sell
109,502
-98
-0.1% -$75.6K 0.17% 124
2023
Q1 		$90.1M Sell
109,600
-1,317
-1% -$993K 0.21% 91
2022
Q4 		$80M Sell
110,917
-6,958
-6% -$5.13M 0.21% 106
2022
Q3 		$81.2M Sell
117,875
-27,536
-19% -$17.3M 0.22% 96
2022
Q2 		$86M Buy
145,411
+32,648
+29% +$21.2M 0.22% 94
2022
Q1 		$78.8M Buy
112,763
+21,852
+24% +$13.8M 0.17% 137
2021
Q4 		$57.4M Buy
90,911
+9,720
+12% +$5.98M 0.12% 189
2021
Q3 		$49.1M Buy
81,191
+11,955
+17% +$7.42M 0.12% 207
2021
Q2 		$38.7M Buy
69,236
+10,597
+18% +$5.37M 0.11% 239
2021
Q1 		$27.7M Sell
58,639
-13,047
-18% -$6.35M 0.1% 270
2020
Q4 		$34.6M Buy
71,686
+6,063
+9% +$3.27M 0.13% 194
2020
Q3 		$36.7M Buy
65,623
+7,202
+12% +$4.37M 0.18% 120
2020
Q2 		$36.4M Buy
58,421
+7,424
+15% +$4.21M 0.22% 103
2020
Q1 		$24.9M Buy
50,997
+8,401
+20% +$3.47M 0.19% 110
2019
Q4 		$16M Buy
42,596
+6,123
+17% +$2.06M 0.1% 248
2019
Q3 		$10.1M Buy
36,473
+1,057
+3% +$313K 0.07% 311
2019
Q2 		$11.1M Sell
35,416
-52,790
-60% -$17.6M 0.08% 278
2019
Q1 		$36.2M Sell
88,206
-1,371
-2% -$565K 0.26% 87
2018
Q4 		$33.5M Buy
89,577
+54,889
+158% +$20.1M 0.3% 69
2018
Q3 		$14M Buy
34,688
+16,774
+94% +$6.38M 0.1% 199
2018
Q2 		$6.17M Buy
17,914
+4,695
+36% +$1.47M 0.08% 154
2018
Q1 		$4.55M Buy
13,219
+2,878
+28% +$1M 0.06% 199
2017
Q4 		$3.89M Buy
10,341
+3,887
+60% +$1.57M 0.05% 225
2017
Q3 		$2.85M Buy
6,454
+1,325
+26% +$630K 0.05% 271
2017
Q2 		$2.56M Buy
5,129
+567
+12% +$248K 0.04% 268
2017
Q1 		$1.77M Buy
4,562
+2,621
+135% +$972K 0.03% 303
2016
Q4 		$713K Sell
1,941
-2,734
-58% -$1.04M 0.02% 360
2016
Q3 		$1.88M Sell
4,675
-767
-14% -$308K 0.04% 248
2016
Q2 		$1.9M Sell
5,442
-4,904
-47% -$1.89M 0.05% 221
2016
Q1 		$3.73M Buy
10,346
+1,825
+21% +$752K 0.1% 152
2015
Q4 		$4.63M Buy
8,521
+1,771
+26% +$960K 0.15% 130
2015
Q3 		$3.14M Buy
6,750
+79
+1% +$42.4K 0.13% 153
2015
Q2 		$3.4M Buy
6,671
+608
+10% +$297K 0.11% 146
2015
Q1 		$2.74M Buy
6,063
+3,607
+147% +$1.53M 0.09% 167
2014
Q4 		$1.01M Buy
2,456
+40
+2% +$15.7K 0.04% 267
2014
Q3 		$871K Buy
+2,416
New +$810K 0.03% 295

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Mirae Asset Global Investments's REGN Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Regeneron Pharmaceuticals (REGN) stake by 11% in Q2 2026, buying an estimated $6.14M and bringing the position to 93,632 shares worth $58.4M. The position accounts for 0.09% of the portfolio, ranked #148.

Mirae Asset Global Investments first reported a position in REGN in Q3 2014 and has held it in 48 quarters since. The position peaked at $109M in Q4 2023. 338 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Mirae Asset Global Investments held 93,632 shares of Regeneron Pharmaceuticals worth $58.4M as of Q2 2026.
  • Mirae Asset Global Investments bought 9,024 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.14M.
  • Regeneron Pharmaceuticals made up 0.09% of Mirae Asset Global Investments's portfolio in Q2 2026, its #148 holding.
  • Mirae Asset Global Investments first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 48 quarters since.
  • Mirae Asset Global Investments's Regeneron Pharmaceuticals position peaked at $109M in Q4 2023.
  • 338 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.